Feasibility trial of ClinTouch-CareLoop Enhanced Management
- Conditions
- Topic: Mental HealthSubtopic: SchizophreniaDisease: SchizophreniaMental and Behavioural DisordersSchizophrenia
- Registration Number
- ISRCTN88145142
- Lead Sponsor
- Manchester Mental Health and Social Care Trust (UK)
- Brief Summary
2020 results in https://pubmed.ncbi.nlm.nih.gov/32788150/ (added 17/08/2020)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 81
1. Diagnosis of schizophrenia or related psychotic disorders, meeting or having met the criteria for such a diagnosis
2. Aged 18 to 65 years
3. Able to provide written and witnessed informed consent; responsible medical officer will be consulted in case of uncertainly
4. Can read and write in English at a level sufficient to understand and complete study-related procedures
5. Not acutely unwell at point of study entry as defined by baseline PANSS total symptom subscale score of less than 110
6. Relapse prone as defined by one or more psychotic episodes requiring inpatient admission in past 2 years as judged from case records
Target Gender: Male & Female; Upper Age Limit 65 years ; Lower Age Limit 18 years
1. Diagnosis of bipolar disorder
2. Inpatient status
3. Unable or unwilling to give written informed consent
4. Unable to understand written materials relating to the study
5. PANSS total score of less than 70 or more than 110
6. Not relapse prone, as defined by fewer than one psychotic episodes requiring inpatient admission in past 2 years as judged from case records
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method